We bring together Australia’s leading researchers, clinicians and consumers, creating a powerful network for dementia prevention, treatment and care.
Melbourne, Victoria
Joined May 2019
- Tweets747
- Following534
- Followers1.6K
- Likes804
Tonight, join @CHeBA_UNSW Centre for Healthy Brain Ageing (CHeBA) for the first in a series of educational COSMIC webinars.
Introduction to Data Harmonisation – A/Prof Matthew Sunderland, University of Sydney, 6pm AEDT
Register: lnkd.in/gxa9NXXa
Firefighters protect our communities — but what's the long-term impact on their brain health? An Australian-first study by @QIMRBerghofer is investigating whether bushfire smoke exposure could affect dementia risk. Firefighters, your input matters 👇
lnkd.in/dxtbf2k7
👁️ Could a simple eye test detect Alzheimer's up to 20 years before symptoms begin? Our partner @AlzheimersRsrch & @uwanews are using a hyperspectral retinal camera to spot amyloid buildup in the eye — and working to make it cheaper & more portable. 🧠
youtube.com/watch?v=hcEFOnE7…
We are remembering ADRF2026 fondly.
Take a moment to enjoy some snippets and highlights of the conference and we hope we will see you next year!
Watch: ➡️youtube.com/watch?v=rhs1CqsR…
#ADRF2026 #dementia #dementiaresearch #ADNeT
Calling all early-career dementia researchers! 📢 Apply now for the @AusDementiaEMCR Sponsorship Program and pair with a senior researcher for strategic career mentoring. 4 meetings. 1 year. Unlimited potential. Find out more:➡️ shorturl.at/wMwgU
#ResearchCareers
More than 450,000 Australians are estimated to be living with dementia. @healthgovau provides a range of support programs and services for people living with dementia and those who care for them. Read more 💻 health.gov.au/dementia
A proud sponsor of #ADRF2026, @healthgovau is investing through the Medical Research Future Fund to support dementia research. Learn more about research supported under the Dementia, Ageing and Aged Care Mission:
💻 health.gov.au/our-work/mrff-…
#dementiaresearch
ADNeT is proud to recognise Prof James Vickers with this year's lifetime achievement award
Through his leadership of Wicking Dementia Research & Education Centre at the University of Tasmania he has been a strong research leader and powerful advocate for people with dementia
James has been a tireless contributor to ADNeT and dementia research and is a very worthy recipient of this honour #ADRF2026
Finishing a brilliant Day One of #ADRF2026 with our Welcome Drinks
Great chance to connect with colleagues from around Australia and overseas
Associate Professor Paul Yates from Austin Health presenting to #ADRF2026 the latest positive results in the treatment of Alzheimer's disease with new disease modifying therapies
Further information on these treatments can be found at lnkd.in/gdHc59bk
"We need to join forces between the delirium and dementia world"
Dr Amy Montgomery from University of Technology Sydney speaking in the Australasian Delirium Association 'Delirium and Dementia' Symposium at #ADRF2026
Professor Jane Alty from University of Tasmania on the potential of digital technology in dementia diagnosis and treatment
A powerful reflection on her own clinical research career and important role her grandfather's experience played in her journey
#ADRF2026
The wonderful St Luke's Care Memory Lane Choir bringing the joy to #ADRF2026
You learn more about the choir's wonderful work here
lnkd.in/gEudtyqw
Professor Perminder Sachdev, Co-Director of UNSW Centre for Healthy Brain Ageing (CHeBA), delivers our first keynote address... a fascinating reflection on the history and latest innovation in vascular dementia treatment and diagnosis #ADRF2026
And we're off and running with #ADRF2026
Our 2026 Convenor Associate Professor Stephanie Ward officially launches this year's Australian Dementia Research Forum
Read the latest news and updates on the Australian Dementia Research Forum, which is just a couple of week away! We are pleased to share the release of our detailed agenda. Find out more: shorturl.at/C8Vk1
#ADRF2026 #dementia #research
ADNeT Director Professor Chris Rowe on our concerns with Cochrane review of anti-amyloid therapies
"These new anti-amyloid therapies are the most significant breakthrough in decades for the treatment of Alzheimer’s." 1/4
"Over time new drugs were added resulting in much greater long-term benefits. This is where the treatment of AD now sits. Current research and trials will develop drugs that add to the benefit from anti-amyloid treatments. " 3/4
Full statement from ADNeT here 4/4
australiandementianetwork.or…